FDA Investigator

Anney Lin

Latest inspection on record: San Diego, United States, May 2026 · records back to 2023

Human DrugsAnimal Drugs & Feeds

FDA inspection record · Last updated July 12, 2026

Overview

  • 23 inspections across 23 sites are on record.
  • 74 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-05-22.

At a glance

Inspections

23

Sites

23

Observations

74

Career since

Oct 2023

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
PETNET SOLUTIONS, INC22 May 2026Human DrugsOn file
Bora Pharmaceutical Laboratories Inc. Zhongli Plant27 Mar 2026Human DrugsOn file
Element Materials Technology Oakland-Concord30 Jan 2026Human DrugsOn file
Life Science Outsourcing, Inc.11 Dec 2025Human DrugsOn file
Skya Health, LLC2 Dec 2025Human Drugs

Sites inspected

PETNET SOLUTIONS, INCSan Diego, United States1 insp.
Bora Pharmaceutical Laboratories Inc. Zhongli PlantTao Yuan Shi, Taiwan1 insp.
Element Materials Technology Oakland-ConcordConcord, United States1 insp.
Life Science Outsourcing, Inc.Brea, United States1 insp.
Skya Health, LLCCorona, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Nathan E Hellman5 shared
Andrew Le4 shared
Gunneet Kaur3 shared
Homero W Aguilar1 shared
Sateesh Kum Sathigari1 shared
Jolanna A Norton1 shared

Full investigator report

Get the verbatim findings behind Anney Lin's 74 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators